129 related articles for article (PubMed ID: 12828586)
61. A randomised comparison of ceftazidime and piperacillin, both in combination with flucloxacillin for treatment of febrile episodes in neutropenic children. Finnish Three-Centre Study.
Perkkiö M; Hovi L; Rajantie J; Lanning M; Salmi T; Williams K; Mäkipernaa A; Ruuskanen O; Renkonen OV; Herva E
Scand J Infect Dis; 1990; 22(2):209-18. PubMed ID: 2192440
[TBL] [Abstract][Full Text] [Related]
62. [Value of the combination of piperacillin and pefloxacin possibly followed by vancomycin in the treatment of febrile neutropenia in nephrotoxic chemotherapy].
Kattan J; Droz JP; Culine S; Ribrag V; Boutan-Laroze A; Andremont A
Bull Cancer; 1992; 79(7):705-12. PubMed ID: 1467596
[TBL] [Abstract][Full Text] [Related]
63. Piperacillin/tazobactam: a pharmacoeconomic review of its use in moderate to severe bacterial infections.
Young M; Plosker GL
Pharmacoeconomics; 2001; 19(11):1135-75. PubMed ID: 11735679
[TBL] [Abstract][Full Text] [Related]
64. Comparative review of combination therapy: two beta-lactams versus beta-lactam plus aminoglycoside.
DeJace P; Klastersky J
Am J Med; 1986 Jun; 80(6B):29-38. PubMed ID: 3524218
[TBL] [Abstract][Full Text] [Related]
65. Piperacillin plus amikacin versus cefotaxime plus amikacin in neutropenic and feverish patients with malignant hemopathies.
Pavone V; Specchia G; Guarini A; Coniglio M; Iaculli L; Girardi F; Colucci A; Liso V
Chemioterapia; 1988 Oct; 7(5):330-5. PubMed ID: 3224402
[TBL] [Abstract][Full Text] [Related]
66. The febrile neutropenic patient: newer options for empirical therapy.
Rubin M; Walsh T; Butler K; Lee J; Lecciones J; Weinberger M; Roilides E; Gress J; Marshall D; Pizzo PA
Haematol Blood Transfus; 1990; 33():531-8. PubMed ID: 2157645
[No Abstract] [Full Text] [Related]
67. Neutropenic infections: a review of the French Febrile Aplasia Study Group trials in 608 febrile neutropenic patients.
Marie JP; Vekhoff A; Pico JL; Guy H; Andremont A; Richet H
J Antimicrob Chemother; 1998 Jun; 41 Suppl D():57-64. PubMed ID: 9688452
[TBL] [Abstract][Full Text] [Related]
68. A multicenter, double-blind, placebo-controlled trial comparing piperacillin-tazobactam with and without amikacin as empiric therapy for febrile neutropenia.
Del Favero A; Menichetti F; Martino P; Bucaneve G; Micozzi A; Gentile G; Furno P; Russo D; D'Antonio D; Ricci P; Martino B; Mandelli F;
Clin Infect Dis; 2001 Oct; 33(8):1295-301. PubMed ID: 11565068
[TBL] [Abstract][Full Text] [Related]
69. Piperacillin or ticarcillin plus amikacin. A double-blind prospective comparison of empiric antibiotic therapy for febrile granulocytopenic cancer patients.
Wade JC; Schimpff SC; Newman KA; Fortner CL; Standiford HC; Wiernik PH
Am J Med; 1981 Dec; 71(6):983-90. PubMed ID: 6459027
[TBL] [Abstract][Full Text] [Related]
70. Restricted use of glycopeptides in paediatric cancer patients with fever and neutropenia.
Simon A; Gröger N; Wilkesmann A; Hasan C; Wiszniewsky G; Engelhart S; Kramer MH; Bode U; Ammann RA; Fleischhack G
Int J Antimicrob Agents; 2006 Nov; 28(5):417-22. PubMed ID: 17046210
[TBL] [Abstract][Full Text] [Related]
71. A randomized trial of Timentin and tobramycin versus piperacillin and tobramycin in febrile neutropenic patients.
Mackie MJ; Reilly JT; Purohit S; Bartzokas CA
J Antimicrob Chemother; 1986 May; 17 Suppl C():219-24. PubMed ID: 3522529
[TBL] [Abstract][Full Text] [Related]
72. [Combination therapy with aztreonam and clindamycin on severe infections accompanying neutropenic patients with hematological disorders].
Urabe A; Takaku F; Mizoguchi H; Nomura T; Aoki N; Yamaguchi H; Mutoh Y; Miura Y; Toyama K; Hirashima K
Jpn J Antibiot; 1990 Oct; 43(10):1713-22. PubMed ID: 2086813
[TBL] [Abstract][Full Text] [Related]
73. Ceftazidime as a single agent in the management of children with fever and neutropenia.
Morgan G; Duerden BI; Lilleyman JS
J Antimicrob Chemother; 1983 Jul; 12 Suppl A():347-51. PubMed ID: 6352641
[TBL] [Abstract][Full Text] [Related]
74. Overview of empiric antibiotic therapy for the febrile neutropenic patient.
Schimpff SC
Rev Infect Dis; 1985; 7 Suppl 4():S734-40. PubMed ID: 3878564
[TBL] [Abstract][Full Text] [Related]
75. [Cefepime-amikacin combination in febrile neutropenic children with malignant hemopathy or tumor].
Marie-Cardine A; Schneider P; Blot N; Tron P; Vannier JP
Arch Pediatr; 2003 Apr; 10(4):307-12. PubMed ID: 12818750
[TBL] [Abstract][Full Text] [Related]
76. Cefepime plus amikacin as an initial empirical therapy of febrile neutropenia in paediatric cancer patients.
Hamidah A; Lim YS; Zulkifli SZ; Zarina AL; Nordiah AJ; Jamal R
Singapore Med J; 2007 Jul; 48(7):615-9. PubMed ID: 17609821
[TBL] [Abstract][Full Text] [Related]
77. Ceftazidime versus ceftazidime plus tobramycin in febrile neutropenic children.
Jacobs RF; Vats TS; Pappa KA; Chaudhary S; Kletzel M; Becton DL
Infection; 1993; 21(4):223-8. PubMed ID: 8225625
[TBL] [Abstract][Full Text] [Related]
78. [Application of the concepts of evidence-based medicine to the evidence on the treatment of febrile neutropenia].
Jarque I; Sanz MA
Enferm Infecc Microbiol Clin; 1999; 17 Suppl 2():95-102. PubMed ID: 10605194
[TBL] [Abstract][Full Text] [Related]
79. Clinical experience with single agent and combination regimens in the management of infection in the febrile neutropenic patient.
Ramphal R; Gucalp R; Rotstein C; Cimino M; Oblon D
Am J Med; 1996 Jun; 100(6A):83S-89S. PubMed ID: 8678102
[TBL] [Abstract][Full Text] [Related]
80. Piperacillin/tazobactam monotherapy versus piperacillin/tazobactam plus amikacin as initial empirical therapy for febrile neutropenia in children with acute leukemia.
Zengin E; Sarper N; Kılıç SC
Pediatr Hematol Oncol; 2011 May; 28(4):311-20. PubMed ID: 21524156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
